Neurocrine Biosciences | NBIX - Текущие активы

Биржевая цена
127.68
Изменение за день
-2.51 -1.93%
Ежемесячно
-2.63%
Ежегодный
19.63%
Q2 прогноз
124.95




Текущие активы Изменить Дата
AbbVie USD 29.06B 523M 2025-12
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 315.19M 24.78M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Repligen USD 1.14B 40.9M 2025-12
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09